XORTX Therapeutics Inc. submitted a 6-K filing on June 11, 2024, indicating its compliance under Form 20-F with the SEC. The filing includes a news release from March 11, 2024, detailing prior events.
AI Assistant
XORTX THERAPEUTICS INC
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.